Conrad Wai

Insider

First SEC filing: April 27, 2023 · Latest: May 28, 2026

On this page

Insider at

0 buys (P) 2 sells (S) Net: $-992,584 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

2 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 15, 2026	CLOV	S	24,215	$4.67	$113,084	1,145,699 Direct	-2.07%	Disposed	-9.4% (price as of 2026-08-20)
May 28, 2026	CLOV	S	220,426	$3.99	$879,500	1,390,056	—	—	6.0% (price as of 2026-08-20)
Sept. 14, 2023	CLOV	F	96,086	$1.13	$108,577	2,653,225 Direct	-3.49%	Disposed	274.3% (price as of 2026-08-20)
June 14, 2023	CLOV	F	86,763	$0.94	$81,557	2,749,311 Direct	-3.06%	Disposed	350.0% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
April 27, 2023	CLOV	Class A Common Stock	—	Direct
April 3, 2023	CLOV	Class A Common Stock	—	Direct

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CEO

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2024	$479,262	—	$2,998,851	—	$976,708	—	$10,877	$4,465,698

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.